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Bethesda, MarylandABSTRACT Pancreatic b-cells sense the ambient blood-glucose concentration and secrete insulin to signal other tissues to
take up glucose. Mitochondria play a key role in this response as they metabolize nutrients to produce ATP and reactive oxygen
species (ROS), both of which are involved in insulin secretion signaling. Based on data available in the literature and previously
developed mathematical models, we present a model of glucose-stimulated mitochondrial respiration, ATP synthesis, and ROS
production and control in b-cells. The model is consistent with a number of experimental observations reported in the literature.
Most notably, it captures the nonlinear rise in the proton leak rate at high membrane potential and the increase in this leak due to
uncoupling protein (UCP) activation by ROS. The functional forms used to model ROS production and UCP regulation yield
insight into these mechanisms, as many details have not yet been unraveled in the experimental literature. We examine short-
and long-term effects of UCP activation inhibition and changes in the mitochondrial density on mitochondrial responses to
glucose. Results suggest increasing mitochondrial density while decreasing UCP activity may be an effective way to increase
glucose-stimulated insulin secretion while decreasing oxidative stress.INTRODUCTIONMitochondria are the main source of free radicals known
as reactive oxygen species (ROS), such as superoxide,
hydrogen peroxide, and hydroxyl radical, within most cells
(1). ROS production in mitochondria is sensitive to the
proton motive force and ROS concentration is regulated by
scavenging enzymes (SE) and the activation of uncoupling
proteins (UCP), which decrease the mitochondrial inner
membrane potential (DJ). The tissue-damaging effects of
ROS have been hypothesized to underlie many well-defined
diseases and clinically relevant complications, includ-
ing those associated with diabetes, Parkinson’s disease, Alz-
heimer’s disease, myopathy, and atherosclerosis (2,3). ROS
have also been shown to play important signaling roles,
such as inmitochondrial biogenesis (4), longevity (5,6), mito-
chondrial evolution and adaptation (3,7), and insulin secretion
(8,9). Therefore, tight regulation of ROS is important to mini-
mize damage without impacting signaling (8).
There is evidence to suggest that ROS and UCP play a key
role in pancreatic b-cell dysfunction under various environ-
mental conditions (8–13). Beta cells are glucose-responsive
cells that sense the ambient plasma-glucose concentration
and secrete insulin to signal other tissues to take up glucose
(10,12). An increase in plasma-glucose levels leads to an
increase in the fluxes through the glycolytic and mitochon-
drial metabolism pathways and an increase in the cellular
ATP/ADP ratio. This causes a series of events to occur in
which ATP-sensitive potassium channels close, voltage-
gated calcium channels open, and insulin secretion is trig-
gered (10,12). Environmental factors, such as low physicalSubmitted May 20, 2009, and accepted for publication October 8, 2009.
*Correspondence: heuettw@niddk.nih.gov
Editor: Arthur Sherman.
 2010 by the Biophysical Society
0006-3495/10/01/0207/11 $2.00activity and hypercaloric lipid-rich diets, are associated
with insulin resistance and decreased glucose-stimulated
insulin secretion in the long term (11,13,14). Therefore,
knowing how ROS and UCP contribute to b-cell function
and insulin secretion, subject to the environment, is impor-
tant (8–13).
Fig. 1 illustrates the mitochondrial pathways involved in
the glucose-sensing process that are relevant to the model
presented here. Beta cells take up glucose (Glu) molecules
from the bloodstream and convert them to pyruvate,
via glycolysis, readying them for the mitochondria. Once
these glycolytic end-products are in the mitochondria, the
hydrogen atoms are removed from the hydrocarbons in the
tricarboxylic acid (TCA) cycle to produce NADH and
FADH2. Calcium, which is injected into mitochondria by
the Ca2þ uniporter and ejected by the Naþ/Ca2þ exchanger
(NaCa), has both depolarizing (electrical) and hyperpolariz-
ing (increasing activity of pyruvate dehydrogenase and key
TCA enzymes (15)) effects on mitochondria (16).
The electron donors, NADH and FADH2, contribute their
electrons to the electron transport chain (ETC). As the elec-
trons flow through the ETC, protons (Hþ) are pumped from
the mitochondrial matrix to the intermembrane space,
increasing DJ. Once protons are in the intermembrane
space, they can flow down the energy gradient, back into
the matrix, through the F1F0-ATP synthase (F1F0). In this
process, the energy stored in the proton gradient is used to
do work by driving the phosphorylation of ADP to ATP.
ATP produced in the mitochondria is transported out of the
matrix by the adenine nucleotide translocator (ANT).
Normally, the electrons flowing through the ETC are
passed on to complex IV and used to reduce a single oxygen
atom to make H2O, but occasionally (and particularly at highdoi: 10.1016/j.bpj.2009.10.012
FIGURE 1 Illustration of mitochondrial processes
involved in glucose sensing and relevant to the model pre-
sented here. Glu, plasma glucose; TCA, tricarboxylic acid
cycle; Cai, intracellular calcium; Cam, mitochondrial
calcium; Uni, Ca2þ uniporter; NaCa, Naþ/Ca2þ exchanger;
ETC, electron transport chain; Hþ, protons; ROS, reactive
oxygen species, DJ, mitochondrial inner membrane
potential; UCPi, inactive uncoupling protein; UCPa, active
uncoupling protein; SEf1, oxidized scavenging enzyme;
SEf2, reduced scavenging enzyme; SEi, inhibited scav-
enging enzyme; ANT, adenine nucleotide translocator;
and F1F0, F1F0-ATP synthase.
208 Heuett and PeriwalDJ) before reaching that point they can react directly with
molecular oxygen to produce superoxide: the primary form
of ROS produced in mitochondria (1,17). ROS can be
removed by antioxidants, i.e., SE, or they can activate
UCP and cause protons to leak back into the matrix, thus
diverting them from the ATP production process. This leak
is in addition to the basal leak that occurs at all times, as
we further describe below.
A much larger proportion of the overall respiratory
activity is wasted as proton leak in b-cells than in other
cell types, including hepatocytes, thymocytes, neurons, and
muscle (18,19). It has been shown that this proton leak
more strongly controls the ATP/ADP ratio in b-cells than
in muscle (19), and UCP (primarily UCP2 in the b-cell)
contributes substantially to the proton leak in b-cells (18).
UCP can be activated by ROS and fatty acids (20), although
the details of the activation and proton transport mechanism
are not yet clear (21). Purine nucleotides (such as GDP) have
classically been considered specific inhibitors of UCP, but
recent experimental results have shown that this is not the
case (22). Results from whole-body UCP2-knockout mice
have provided evidence for the role that UCP2 plays in
glucose-stimulated insulin secretion (8,10), but b-cell
specific knockouts have not yet been developed.
To investigate the roles of ROS and UCP regulation in
response to nutrient inputs in b-cells, we developed a mathe-
matical model based on previously derived models (16,23–
25) and the current published data (18–20,26). The model
captures the behavior of mitochondrial respiration and
ATP synthesis, and goes beyond the previously developed
models to include dynamics related to ROS production and
the SE and UCP defense mechanisms (Fig. 1 and ModelingBiophysical Journal 98(2) 207–217Methods). We parameterize the model using experimental
results of UCP content and the proton leak rate from the liter-
ature (Modeling Methods). To our knowledge, mechanistic
details of the processes of ROS production and UCP regula-
tion have not yet been fully experimentally elucidated in the
literature. The fact that the mathematical model can match
existing experimental observations implies that the func-
tional forms of the fluxes used in the model are sufficient
to capture the behaviors observed in experiments without
requiring more complicated or detailed mechanistic relation-
ships. Finally, we use the model to investigate the effects of
UCP and mitochondrial density on ROS and ATP production
in response to glucose (Results).MODELING METHODS
The model presented here builds upon previously developed mathematical
models (16,23–25). Assuming a constant mitochondrial volume, the govern-
ing dynamic equations for the concentrations of the mitochondrial variables
and the inner membrane potential are as follows. The mitochondrial NADH
and FADH2 concentrations, NADHm and FADH2,m (mM), respectively,
change according to
dNADHm
dt
¼ gðJN;Glu  JO;N  JROS;NÞ; (1)
dFADH2;m
dt
¼ gðJF;Glu  JO;F  JROS;FÞ; (2)
where JN,Glu is the glucose-dependent NADH production rate, JO,N is the
rate of oxidation of NADH that results in the consumption of a single oxygen
atom to produce H2O, JROS,N is the NADH-dependent rate of ROS produc-
tion, and JF,Glu, JO,F, and JROS,F are the corresponding FADH2-related rates.
Each of the fluxes noted here and below are in units of mM/ms. The value
g ¼ 0.001 mM/mM is used to convert mM to mM units.
TABLE 1 Model parameters
Parameter Value Units Ref.
g 0.001 mM/mM —
fm 0.0003 Unitless (23)
Cm 1.8 mM/mV (23)
NADtot 10 mM (23)
FADtot 2.75 mM (24,27)
Atot 15 mM (23)
SEtot 0.7 mM (28)
t 10 min (27)
p1 6 mM/ms (23)
p2 141 mV (16,19,23)
p3 5 mV (16,19,23)
p4 0.37 mM/ms (23,24)
p5 0.5 Unitless —
p6 1.5 /mM/ms (26)
p7 0.55 /mM/ms (26)
p8 0.117 /ms (26)
p9 5.5  108 /ms (29)
p10 5.3  108 mM/ms (29)
p11 2.5  106 /mM/ms (18,29)
p12 1.93  107 /ms (29)
p13 0.0214 /mV (18–20)
p14 8.4  104 mM/ms/mV (18–20)
p15 0.0014 /ms/mV (18–20,29)
p16 0.03 /mM/ms (23,25)
p17 0.023 /mV (23,25)
p18 0.03 mM/ms (23,25)
p19 3.752 mM (23,25)
p20 0.0185 /mV (23,25)
p21 0.035 mM/ms (25)
p22 0.531 Unitless (25)
p23 0.1 mM (25)
p24 12.171 mM/ms (16,18,23)
p25 0.0114 Unitless (16,18,23)
p26 154 mV (16,18,23)
p27 8.5 mV (16,18,23)
p28 2.554 mM/ms (23)
p29 0.151 Unitless (23)
p30 9.25  104 /mV (23)
Autoregulation of ROS via UCP Control 209The mitochondrial Ca2þ concentration, Cam (mM), changes according to
dCam
dt
¼ fmðJuni  JNaCaÞ; (3)
where Juni and JNaCa correspond to the uniporter and Na
þ/Ca2þ exchanger
rates, respectively. The value fm ¼ 0.0003 is the fraction of free mitochon-
drial Ca2þ (23).
The mitochondrial ATP concentration, ATPm (mM), changes according to
dATPm
dt
¼ gðJTCA;Glu þ JF1F0  JANTÞ; (4)
where ATP is produced from the TCA cycle (assuming immediate conver-
sion from GTP) and the F1F0-ATP synthase at the rates JTCA,Glu and JF1F0,
respectively, and taken out of the matrix by the ANT at the rate JANT.
Superoxide, being the primary form of reactive oxygen species produced
in mitochondria (1), is the form we are most interested in modeling, and the
one that we generally refer to as ‘‘ROS’’ hereafter. ROS levels increase with
the fluxes JROS,N and JROS,F, and decrease through scavenging removal at
the rate JSE,1 þ JSE,2 þ JSE,3 and UCP activation at the rate JUCP,a, giving
dROS
dt
¼ 2ðJROS;N þ JROS;FÞ  JSE;1  JSE;2  JSE;3
 JUCP;a: (5)
The stoichiometric factor of two corresponds to two ROS produced per
two NADH or FADH2 electrons, as described below. ROS represents the
ROS concentration (mM).
Manganese superoxide dismutase is the scavenging enzyme that catalyzes
the removal of superoxide, and we generally refer to it as ‘‘SE’’ hereafter.
The oxidized and reduced SE concentrations, SEf1 and SEf2 (mM), respec-
tively, change according to the scavenging reaction rates, JSE,1, JSE,2,
JSE,3, and JSE,4, such that
dSEf1
dt
¼ JSE;2 þ JSE;4  JSE;1; (6)
dSEf2
dt
¼ JSE;1  JSE;2  JSE;3: (7)
Beta cells primarily express UCP2, and it is this form of uncoupling protein
that we generally refer to as ‘‘UCP’’ hereafter. Inactive and active UCP
concentrations, UCPi and UCPa (mM), respectively, change according to
dUCPi
dt
¼ JUCP;p  JUCP;a  JUCPi;d; (8)
dUCPa
dt
¼ JUCP;a  JUCPa;d; (9)
where inactive UCP are produced at the rate JUCP,p, UCP are activated at the
rate JUCP,a, and both forms decay at their respective rates JUCPi,d and JUCPa,d.
The energy stored across the inner membrane, i.e., the proton motive
force, has voltage (DJ) and pH (DpH) components. Past models have taken
DpH to be constant (23,25), and experimental results used here to parame-
terize our model were typically obtained after the addition of a chemical
(nigericin) to collapse DpH (18–20). We, therefore, only consider changes
in DJ, but dependencies on DJ can be replaced to include a variable
DpH (as was the case in Cortassa et al. (24)) for more general applications.
The mitochondrial membrane potential changes according to
dDJ
dt
¼ JHres;N þ JHres;F þ JHros;N þ JHros;F  JH;ATP
 JHþ ;leak  JANT  JNaCa  2Juni

Cm; (10)where JHres,N, JHres,F, JHros,N, JHros,F, and JH,ATP are the proton effluxes
from the matrix to the intermembrane space associated with JO,N, JO,F,
JROS,N, JROS,F, and JF1F0, respectively, and JH
þ, leak is the proton leak
rate. Cm ¼ 1.8 mM/mV is the mitochondrial capacitance (23).
We assume conservation of the mitochondrial concentrations
(23,24,27,28)
NADtot ¼ NADm þ NADHm ¼ 10 mM; (11)
FADtot ¼ FADm þ FADH2;m ¼ 2:75 mM; (12)
Atot ¼ ADPm þ ATPm ¼ 15 mM; (13)
SEtot ¼ SEf1 þ SEf2 þ SEi ¼ 0:7mM; (14)
where NADm, FADm, and ADPm are the mitochondrial NAD
þ, FAD, and
ADP concentrations (mM), respectively, and SEi is the concentration of
inhibited SE (mM).
Those fluxes in Eqs. 1–10 that were simplified from previously developed
models are described in detail in the Appendix. In the following subsections,
we describe the fluxes related to ROS, SE, and UCP, which have not been
previously modeled. Each parameter value used in the model is given in
Table 1.Biophysical Journal 98(2) 207–217
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As DJ increases, it becomes more difficult for the ETC complexes to pump
protons against that potential. Instead of completing their trip through the
ETC, electrons in the ETC begin reacting directly with molecular oxygen,
reducing it to form superoxide. Although several details of mitochondrial
ROS production have been revealed, exact mechanisms remain obscure
(1,17). We, therefore, model the ROS production rate phenomenologically,
based on the form of the NADHm and FADH2, m oxidation rates in Eqs. 32
and 34, as
JROS;N ¼ p1

NADHm
NADm
1=2
1 1
1 þ eðDJp2Þ=p3

; (15)
JROS;F ¼ p4

FADH2;m
FADm
1=2
1 1
1 þ eðDJp2Þ=p3

; (16)
respectively, where p1 ¼ 6 mM/ms, p2 ¼ 141 mV, p3 ¼ 5 mV, and p4 ¼
0.37 mM/ms. The parameters were estimated from the NADHm and
FADH2,m oxidation rates of previously developed models and (in the case
of p2) by fitting data from the literature, as described in the Appendix.
Because each of the electrons donated by NADHm and FADH2,m react
with molecular oxygen to yield a superoxide, a factor of two is reflected
with each of these rates in Eq. 5. Fig. 2 illustrates the ROS production
rate that results from NADHm oxidation. That from FADH2,m oxidation
has the same qualitative behavior.
The electrons do not complete the ETC circuit when ROS are produced.
Instead, they can be diverted from their course at various points, such as, for
example, the electron transfer points of complex III (1,17). This means that
fewer protons may be pumped out of the mitochondrial matrix when ROS
are produced, depending on when the electrons exit the ETC, than when
NADHm and FADH2,m oxidation produces H2O. Because, to our knowl-
edge, no experimental evidence exists to quantify the number of protons
pumped out of the matrix when ROS are produced, we estimate that, on
average, it results in only half of the protons being pumped out than would
be when the case H2O is produced. Therefore, we model the rate of proton
efflux resulting from the oxidation of NADHm and FADH2,m to produce
ROS as
JHros;N ¼ 12p5JROS;N; (17)0 0.5 1 1.5
0
0.1
0.2
NADH
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FIGURE 2 ROS production rate from NADHm oxidation for physiolog-
ical (A) concentrations of NADHm (DJ¼ 120 mV) and (B) DJ (NADHm¼
0.75 mM).
Biophysical Journal 98(2) 207–217JHros;F ¼ 8p5JROS;F; (18)
respectively, based on the form of Eqs. 33 and 35, where p5 ¼ 0.5. These
rates have the same qualitative behavior as JROS,N and JROS,F (Fig. 2). Devi-
ations in the value of p5 do not significantly impact the overall qualitative
behavior of the model, as the contribution from the ROS production process
to the total number of protons being pumped out of the matrix during
NADHm and FADH2,m oxidation is relatively small under normal condi-
tions. Simulations of the complete model with p5 taken to the extreme values
of 0 or 1 resulted in miniscule changes (<0.5%) inDJ at the highest glucose
concentrations (20 mM) examined below.
Scavenging enzymes
Once ROS are produced, they can be removed from the system by SE.
Manganese superoxide dismutase catalyzes the dismutation of two superox-
ides into oxygen and hydrogen peroxide as it cycles (reactions JSE,1 and
JSE,2 in Fig. 1) between oxidized and reduced forms, which we call SEf1
and SEf2, respectively. SEf2 can become inhibited to form SEi when it reacts
with ROS (reaction JSE,3 in Fig. 1), but the inhibited form can become active
one again (JSE,4 in Fig. 1). We use the scheme shown in the central part of
Fig. 1, with mass action relationships and rate parameters measured by
Hearn et al. (26), to model the rates associated with the process of ROS
removal by SE as
JSE;1 ¼ p6SEf1ROS; (19)
JSE;2 ¼ JSE;3 ¼ p7SEf2ROS; (20)
JSE;4 ¼ p8SEi; (21)
where p6 ¼ 1.5/mM/ms, p7 ¼ 0.55/mM/ms, and p8 ¼ 0.117/ms.
UCP regulation and proton leak
UCP are dynamically regulated in b-cells, with concentrations increasing
with sustained increases in nutrient level exposure (11,13,29). They remain
in an inactive state unless acted upon by endogenous activators, such as ROS
and fatty acids (20). UCP have a short half-life of ~60 min, and this is
thought to be the mechanism through which the activated UCP proton
leak ceases (29). Here, we assume ROS serves as a signal for UCP produc-
tion and it is responsible for UCP activation. We model the UCP regulation
processes according to the scheme shown on the right of Fig. 1, with the
rates of UCP production (JUCP,p), activation (JUCP,a), and decay (JUCPi,d
and JUCPa,d) given by
JUCP;p ¼ p9ROSdelay þ p10; (22)
JUCP;a ¼ p11UCPiROS; (23)
JUCP;d ¼ p12UCPi; (24)
JUCPa;d ¼ p12UCPa; (25)
respectively. The parameter values, p9 ¼ 5.5  108/ms, p10 ¼ 5.3 
108 mM/ms, and p11 ¼ 2.5  106/mM/ms, were determined by running
simulations of the complete model and performing a least-squares fit of
the steady-state UCPtot ¼ UCPi þ UCPa to data from the literature (29),
as shown in Fig. 3. The parameter p12 ¼ 1.93  107/ms was measured
experimentally by Azzu et al. (29). ROSdelay(t) ¼ ROS(t – t) is a delay vari-
able that follows ROS levels, where t> 0 accounts for the time it would take
for the signal to propagate and for UCP to be translated and inserted into the
membrane. In the results shown below, we estimate t ¼ 10 min (27).
Activated UCP contributes to the leak of protons from the intermembrane
space to the matrix, effectively decreasing DJ and diverting protons from
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FIGURE 4 The nonlinear proton-leak rate in the absence (dashed curve)
and presence (solid curve) of UCP and the proton efflux rate, JH
þ, efflux ¼
JHres,N þ JHres,F þ JHros,N þ JHros,F (dash-dotted curve), are shown for
steady-state model simulations as a function of DJ with Glu ¼ 11 mM
and Cam ¼ 0.3 mM. Data from Echtay et al. (20) (squares), Affourtit and
Brand (18) (circles), and Affourtit and Brand (19) (triangles) are shown
for comparison.
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FIGURE 3 Steady-state simulations were run for fixed glucose concentra-
tions and total UCP content was calculated. Intracellular calcium was held
constant at 0.2 mM. Data from Azzu et al. (29) are shown for comparison.
Autoregulation of ROS via UCP Control 211the ATP production process while reducing the rate of ROS production
(13,20). This is a defense mechanism implemented through ROS self-regu-
lation by negative feedback. The proton leak rate is a nonlinear, DJ-depen-
dent rate. It has an active UCP component and a basal component, which we
assume includes the leak through ANT and other pathways. Although the
basal leak rate is energization-dependent (22), this dependence is not yet
well understood. Because we are primarily interested in the effects of
UCP-mediated leak beyond the basal leak, we consider the basal leak
component to be dependent only on DJ in our model. We model the proton
leak rate as
JHþ;leak ¼ DJep13DJðp14 þ p15UCPaÞ: (26)
Fig. 4 illustrates the steady-state DJ dependence of JH
þ,leak for
Glu ¼ 11 mM and Cam ¼ 0.3 mM. The solid curve in Fig. 4,
JHþ ;leak ¼ 0:0012DJ expð0:0214DJÞ, was fit by least-squares to b-cell
proton leak rate measurements from Echtay et al. (20) and Affourtit and
Brand (18,19) (shown in Fig. 4 as squares, circles, and triangles, respec-
tively). An estimate that UCP accounts for 30% of the proton leak rate in
b-cells grown in 11 mM glucose (18) was then used to determine p13 ¼
0.0214/mV and p14 ¼ 8.4  104 mM/ms/mV. The dashed curve in
Fig. 4 shows the proton leak rate in the absence of UCP. The parameter
p15 ¼ 0.0014/ms/mV was determined in combination with p9, p10, and
p11, by fitting data related to UCPtot, as described above, with the constraint
that p15UCPa ¼ 3.6  104 mM/ms/mV at Glu ¼ 11 mM and Cam ¼
0.3 mM.
Model implementation
The model is implemented in MATLAB (The MathWorks, Natick, MA) and
available at http://lbm.niddk.nih.gov/heuettw/wjh/Publications.html. Least-
squares calculations used to determine p2, p9, p10, p11, p13, p14, and p15
were performed using the MATLAB optimization toolkit.RESULTS
Inhibiting UCP activation
Pancreatic b-cells secrete insulin when stimulated by
increasing plasma-glucose levels: a response mediated byan increase in the intracellular ATP/ADP ratio. Given that
UCP divert protons from ATP production, and thus from
the insulin secretion signal, it may be thought that inhibiting
UCP expression or activity is a possible therapeutic approach
to improve glucose-stimulated insulin secretion (10). We
examined the long-term effect of inhibiting UCP activation
by perturbing the parameter p11 in our model from its orig-
inal value of 2.5  106/mM/ms, and comparing the mito-
chondrial variables’ steady-state responses to glucose levels
under normal and inhibited UCP activation scenarios. Fig. 5
shows the results for the normal UCP activation case (solid
curves) and the cases in which UCP activation was inhibited
by 90% (dashed curves) and 100% (dash-dotted curves).
Model simulations show that as the plasma-glucose level
increases, so does the mitochondrial membrane potential
(Fig. 5 A) and the ATP/ADP ratio (Fig. 5 B). Increasing
DJ increases mitochondrial ROS production (Fig. 5 C),
which challenges the SE and UCP defense mechanisms
(Fig. 5, D–F). Inhibiting UCP shifts the ATP/ADP ratio
curve up, and increases the rate at which it increases with
respect to glucose. Between Glu ¼ 5 mM and 10 mM, the
ATP/ADP ratio increases by 50% under normal conditions,
by 52% when UCP activation is inhibited by 90%, and by
58% when UCP activation is completely inhibited. This
shows that blocking UCP activation increases the ATP/
ADP ratio, and might be expected to increase the glucose-
stimulated insulin secretion response. The negative side
effect of blocking UCP activation is that ROS levels are
also increased to the point that there is 25% more ROS at
Glu ¼ 5 mM when there is no UCP activation than whenBiophysical Journal 98(2) 207–217
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212 Heuett and PeriwalUCP is activated normally. Long-term exposure to these
increased ROS levels would be expected to cause additional
oxidative damage. This is in fact the case according to exper-
iments, which have shown that the chronic absence of UCP
causes persistent oxidative stress and impairment of b-cell
function (8).
Increasing mitochondrial density
Experimental observations have attributed an increase in
mitochondrial function to an increase in mitochondrial
density, i.e., the mitochondrial content of a cell (30). We
investigated the long-term effects of changes in the mito-
chondrial content of a cell by dividing our model parameters
p16, p18, p21, and p28 by a mitochondrial density parameter,
which we call p0, where p0 ¼ 1 represents the typical mito-
chondrial content, and p0 > 1 represents a proportional
increase in mitochondrial content. We then compared the
mitochondrial variables’ steady-state responses to glucose
levels under normal and increased mitochondrial density
scenarios. Fig. 6 shows the results for the normal mitochon-
drial content case (solid curves), the effects of increasing the
mitochondrial density by one-third (dashed curves), and the
combined effects of such an increase with complete inhibi-
tion of UCP activation (dash-dotted curves).Biophysical Journal 98(2) 207–217Increasing the mitochondrial density by one-third, i.e.,
setting p0 ¼ 4/3, increases the rate at which the ATP/ADP
ratio increases with respect to glucose, such that the ratio
increases by 58% between Glu ¼ 5 mM and 10 mM, as
compared to the 50% increase under normal conditions dis-
cussed above. At the same time, ROS levels are decreased to
the point that there is 64% less ROS at Glu ¼ 5 mM when
p0 ¼ 4/3 than to when p0 ¼ 1. The rate at which the ATP/
ADP ratio increases with respect to glucose increases even
further when both the mitochondrial density is increased
by one-third and UCP activation is completely blocked
(i.e., p0 ¼ 4/3 and p11 ¼ 0), such that the ratio increases
by 67% between Glu ¼ 5 mM and 10 mM. ROS levels in
this case remain low, at 59% less than that of normal condi-
tions. These results suggest that an increase in mitochondrial
density can increase mitochondrial function, primarily by
distributing the metabolic load among more mitochondria,
and may increase glucose-stimulated insulin secretion while
decreasing oxidative stress.
Short-term responses to a glucose proﬁle
Generally, experiments examining mitochondrial ROS and
UCP regulation deal with long-term exposure to nutrient
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FIGURE 7 Simulations of mitochondrial (B) DJ, (C) ATP/ADP, (D)
ROS, (E) SEf1 þ SEf2, (F) UCPa, and (G) UCPi time-dependent responses
to (A) a plasma glucose profile from Breda et al. (31), under normal (solid
curves) and inhibited (dashed and dash-dotted curves) UCP activation
conditions. Dash-dotted curves show the combined effects of complete
UCP activation inhibition with an increase of one-third in the mitochondrial
density, p0. Intracellular calcium was held constant at 0.2 mM.
Autoregulation of ROS via UCP Control 213levels (10–13), but ROS have been shown to have important
temporal roles as signals in response to glucose in b-cells
(8,9). To examine the effects of blocking UCP activation
and increasing the mitochondrial density in the short term,
we simulated the mitochondrial variables’ responses to a
glucose profile measured by Breda et al. (31). The glucose
profile was measured for a total of 300 min, starting from an
initial value of Glu ¼ 5.4 mM, and reaching a maximum of
Glu ¼ 9.5 mM at 60 min. We assumed that the initial condi-
tions for the simulations were resting, steady-state conditions
determined by the initial glucose concentration. Fig. 7 shows
the glucose profile and the results of the simulations for
normal UCP activation and mitochondrial density (solid
curves), complete inhibition of UCP activation (dashed
curves), and complete inhibition of UCP activation in combi-
nation with an increase of one-third in the mitochondrial
density (dash-dotted curves). In the cases involving inhibition
ofUCP activation, the inhibitionwas assumed to occur instan-
taneously and completely, i.e., p11/ 0, at time 0 min, and to
persist throughout the 300-min simulation.
Model simulations show that ROS increases in the short
term to a maximum of three times its initial value undernormal UCP activation and mitochondrial density condi-
tions. Starting from the same initial condition, the sudden
blocking of UCP activation causes a larger increase in
ROS to 3.7 times the initial value. This supports the sugges-
tion put forward by Pi et al. (8), that although long-term
absence of UCP can cause persistent oxidative stress
and impair b-cell function, the acute inhibition of UCP acti-
vation may allow for a greater ROS signal, and perhaps
an improved glucose-stimulated insulin secretion response.
The combination of the sudden blocking of UCP activation
with a persistent one-third increase in the mitochondrial
density, i.e., p0¼ 4/3, causes an increase in ROS to 3.2-times
its initial value, but the initial value for this case has a
lower initial, steady-state ROS value that is 64% less than
the other two cases because of the increased mitochondrial
density.
For each of the short-term simulations discussed above,
we estimated the parameter t was 10 min. Additional simu-
lations (not shown) were performed for other values of t
between 0 and 150 min, assuming normal UCP activation
and mitochondrial density. Such variations resulted in no
qualitative differences and only miniscule changes (<0.5%)
in all the mitochondrial variables at their peak values, with
the exception of the UCP variables, which were shifted in
time according to t. In all cases, there was sufficient UCPi
available to meet demand in response to ROS levels, and
UCPtot ¼ UCPi þ UCPa increased to a maximum of only
5% more than its initial value at time 0 min, regardless of t.DISCUSSION
Mitochondria play a key role in whole-body metabolism:
a complex process involving many different tissues, such
as muscle, fat, liver, and pancreas, in an intimate relationship
between signaling pathways and metabolic networks (14).
Mitochondrial dysfunction can result from several factors,
including oxidative stress, which inhibits the ability of mito-
chondria to maintain DJ (3). Emerging evidence supports
the hypothesis that mitochondrial dysfunction causes insulin
resistance and hyperglycemia: prominent features of type 2
diabetes (14). Such analyses have emphasized the critical
roles of ROS, UCP, and mitochondrial density in disease
progression.
Although many of the details of mitochondrial ROS
production and UCP regulation are still being unraveled
experimentally, we developed a state-of-the-data model,
based on the data and information available, to integrate the
current understanding andmake predictions about the system.
The model goes beyond previously developed models by
incorporating ROS production and the activity of SE and
UCP. Importantly, it captures the nonlinear behavior of the
proton-leak rate as a function of membrane potential and
UCP activity. The model’s simplicity is an advantage in
that it allows easy manipulation and transference (i.e.,
through parameter adjustments), making it useful for researchBiophysical Journal 98(2) 207–217
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developed for b-cell mitochondria, the model allows us to
make inferences and propose hypotheses related to the
roles ROS, UCP, and mitochondrial density play in b-cell
function and insulin secretion under various environmental
conditions.
The functional forms used to model ROS production, UCP
regulation, and proton leak rates are important. Many details
related to these mechanisms are still unknown in the experi-
mental literature. We based the form of the ROS production
fluxes on those of the NADH and FADH2 oxidation rates,
and used simple mass action relationships, without saturation,
cooperativity, or other more complicated relationships, to
model UCP production, activation, and decay. The fact that
the model can match reasonably complex experimental data
implies that the functional forms used contain enough detail,
without requiring the burden of more complicated relation-
ships, to capture the existing experimental observationswithin
physiological ranges. In turn, these functional forms may
provide useful insight to enhance experimental deductions.
Model simulations can be used to examine the short- and
long-term effects that perturbations in UCP activity and
mitochondrial density have on b-cell function. They predict
that short-term inhibition of UCP will prevent the diversion
of protons from ATP production and enhance ROS
signaling. Such a response may improve glucose-stimulated
insulin secretion (8). However, long-term inhibition of UCP
is predicted to cause a sustained increase in ROS levels, and
would therefore be expected to cause persistent oxidative
stress. By increasing the mitochondrial density within the
cell, the metabolic load can be shared among more mito-
chondria, and it is predicted that this serves to increase the
ATP/ADP ratio response to glucose while decreasing oxida-
tive stress. Experimentally, the perturbations in UCP activity
and mitochondrial density could potentially be accomplished
using pharmacological UCP inhibitors, such as genipin (32),
and activators of the sirtuin, SIRT1, and the peroxisome pro-
liferator-activated receptor-g coactivator, PGC1a, which
regulate mitochondrial biogenesis (4,6).
There are multiple limitations to the current model, such as
it does not include adaptive responses, such as increases in
antioxidant levels in response to elevated ROS levels (8),~Juni ¼ Jmax;uni
Cai
Ktrans

1 þ Cai
Ktrans
3
2FðDJ DJoÞ
RT"
1 þ Cai
Ktrans
4
þ L
1 þ Cai
Kact
na
#
1 e2FðDJDJ
oÞ
RT
;which might occur in living cells. We only considered super-
oxide as the endogenous UCP activator here, but otherBiophysical Journal 98(2) 207–217potential activators, e.g., other forms of ROS, such as
hydroxynonenal, and fatty acids, have been identified exper-
imentally (20,22). Although the intracellular calcium level
was held constant for the simulations presented, it would
actually be expected to vary and experience bursts and oscil-
lations in response to glucose (25), potentially exaggerating
the results shown here, given the polarizing effects calcium
has on mitochondria (15,16). We also neglected the DpH
component of the proton motive force (18–20,23,24) and
the energization-dependent properties of ANT and other
pathways in the proton leak rate (18,22), for reasons dis-
cussed in Modeling Methods. These and more are acknowl-
edged limitations, but each limitation can and will be
addressed in future generations of the model.
The fact that common human diseases and changes in
metabolic states are often associated with relatively small
changes in many enzymes, rather than twofold or greater
changes in only a few enzymes, illustrates the crucial impor-
tance of quantitative modeling in their investigation. The
model presented here provides a way to test the current
understanding of a complex system, and examine how
perturbations may affect the system over time.APPENDIX
Much of the basis of our model comes from a model originally derived by
Magnus and Keizer (23,25). We have simplified their model by making
several approximations, similar to those made by Bertram et al. (16), as
described below. Because b-cells operate at lower membrane potentials
than skeletal muscle and cardiac cells, and because the earlier models
were developed using data from the latter, the inflection points of the
DJ-dependent curves from the earlier models were adjusted. We used the
factors g1 and g2 as described below, to better agree with the experimental
observations of the DJ-dependence of the proton efflux rate, JH
þ,efflux, in
b-cells, as measured by Affourtit and Brand (19) and shown in Fig. 4. Mag-
nus and Keizer (23) noted that these factors may represent the fraction of the
potential that is actually felt by the enzymes in the membrane.
Calcium handling
We include the two major mitochondrial calcium transporters, i.e., the Ca2þ
uniporter and the Naþ/Ca2þ exchanger, in our model. The Ca2þ uniporter,
which injects cytosolic Ca2þ into the mitochondria, and depends on the
intracellular Ca2þ concentration (Cai) and the inner membrane potential,
was modeled by Magnus and Keizer (23,25) aswhere Jmax,uni ¼ 8.33 mM/ms, Ktrans ¼ 16 mM, and F/RT ¼ 0.037/mV
is Faraday’s constant divided by the gas constant and temperature,
Autoregulation of ROS via UCP Control 215DJo ¼ 91mV, L ¼ 50, Kact ¼ 0.38 mM, and na ¼ 2.8. We approximate ~Juni
in our model with the simpler form
Juni ¼ p16Ca2i ep17DJ: (27)
Fig. S1 in the Supporting Material illustrates the uniporter Ca2þ-transport
rate, as calculated by the two models.
The Ca2þ efflux through the Naþ/Ca2þ exchanger was modeled by Magnus
and Keizer (23,25) as
~JNaCa ¼ Jmax;NaCa e
bFðDJDJoÞ
RT
1 þ KNa
Nai
n
1 þ KCa
Cam
;
where Jmax,NaCa ¼ 0.3694 mM/ms, b ¼ 0.5, KNa ¼ 9.4 mM, Nai ¼ 30 mM,
n ¼ 3, and KCa ¼ 3.75 mM. We approximate ~JNaCa in our model with the
simpler form
JNaCa ¼ p18Cam
p19 þ Came
p20DJ: (28)
Fig. S2 illustrates the Naþ/Ca2þ-exchanger rate, as calculated by the two
models.~JO;N ¼ 0:5rres;N

ra10
6DpH þ rc1e
6FDJB
RT

e
FAres;N
RT  rae
6g1FDJ
RT þ rc2e
FAres;N
RT e
6g1FDJ
RT
1 þ r1e
FAres;N
RT

e
6FDJB
RT þ

r2 þ r3e
FAres;N
RT

e
6g1FDJ
RT
;Reducing equivalents
On the basis of stoichiometry and a quasi-steady-state glucose-metabolism
assumption, Magnus and Keizer (25) modeled the rate at which glycolytic
end-products are made available to mitochondria as
~Jgly¼ bmaxð1 þ b1GluÞb2GluATPi
1þb3ATPiþð1þb4ATPiÞb5Gluþð1þb6ATPiÞb7Glu2
;
where bmax ¼ 2.625 mM/ms/mM, b1 ¼ 1.66/mM, b2 ¼ 0.0249/mM,
b3 ¼ 4/mM, b4 ¼ 2.83/mM, b5 ¼ 1.3/mM, b6 ¼ 2.66/mM, and b7 ¼
0.16/mM2. Glu is the plasma-glucose concentration (mM) and ATPi is the
intracellular ATP concentration (mM). bmax includes a cytosol/mitochondria
volume ratio factor (1/0.09), so that the flux is in terms of mitochondrial
volume. As the ~Jgly dependence on ATPi is extremely weak, we neglect it
by setting ATPi ¼ 1.8 mM, which is in the middle of the physiological range
(25). We then approximate the glucose-availability rate in our model with
the simpler form
Jgly ¼ p21

Glu
1mM
1=2
: (29)
Modified forms of the Magnus and Keizer (25) glucose-dependent NADHm
and FADH2,m production rates are given by
~JN;Glu ¼ 8f ðCamÞ~Jgly;
~JF;Glu ¼ 4f ðCamÞ~Jgly;
respectively, wheref ðCamÞ ¼ 1	  2
;
1 þ u2 1 þ u1 1 þ Cam
KCam
and where u1 ¼ 15, u2 ¼ 1.1 and kCam ¼ 0.05 mM. We approximate ~JN;Glu
and ~JF;Glu in our model as
JN;Glu ¼ 8p22Jgly

Cam
p23 þ Cam

; (30)
JF;Glu ¼ 4p22Jgly

Cam
p23 þ Cam

; (31)
respectively. Fig. S3 illustrates the NADHm production rate computed by the
two models. JF,Glu has the same qualitative behavior.Electron transport chain
The rate of oxidation of NADHm that results in the consumption of a
single oxygen atom to produce H2O was modeled by Magnus and Keizer
(23) aswhere
Ares;N ¼ RT
F
ln

Kres;N

NADHm
NADm
1=2
;
and where rres,N ¼ 500 mM, ra ¼ 6.394  1013/ms, DpH ¼ –0.4, DJB ¼
50 mV,g1 ¼ 0.97, rc1 ¼ 2.656  1022/ms, rc2 ¼ 8.632  1030/ms, r1 ¼
2.077 1018, r2¼ 1.728 109, r3¼ 1.059 1026, and Kres,N¼ 1.35
1018. The value g1 was adjusted from its original value of 0.85 in Magnus
and Keizer (23) to better agree with experimental observations of the DJ-
dependence of the proton efflux rate, JH
þ, efflux, shown in Fig. 4. We approx-
imate ~JO;N in our model with the simpler form
JO;N ¼ p1

NADHm
NADm
1=2
1
1 þ eðDJp2Þ=p3

: (32)
Fig. S4 illustrates the H2O production rate that results from NADHm oxida-
tion, as calculated by the two models. Using a factor of six that corresponds
to the ideal Hþ:e– ratio, we approximate the proton efflux rate resulting from
this H2O production as (23)
JHres; N ¼ 12JO; N; (33)
which has the same qualitative behavior as JO,N (Fig. S4). Note that the
oxidation rate of NADHm resulting in H2O production decreases as DJ
increases, illustrating metabolic control as it becomes more difficult to
pump protons against a large potential (16).Biophysical Journal 98(2) 207–217
216 Heuett and PeriwalSimilar to that of NADHm, the rate of reduction of a single oxygen atom
from the oxidation of FADH2,m can be modeled as (23,24)~JO;F ¼ 0:5rres;F

ra10
4DpH þ rc1e
4FDJB
RT

e
FAres;F
RT  rae
4g1FDJ
RT þ rc2e
FAres;F
RT e
4g1FDJ
RT
1 þ r1e
FAres;F
RT

e
4FDJB
RT þ

r2 þ r3e
FAres;F
RT

e
4g1FDJ
RT
;where
Ares;F ¼ RT
F
ln

Kres;F

FADH2;m
FADm
1=2
;
and where rres,F ¼ 1250 mM and Kres,F ¼ 5.765  1013. We approximate
~JO;F in our model with the simpler form
JO;F ¼ p4

FADH2;m
FADm
1=2
1
1 þ eðDJp2Þ=p3

: (34)
Using a factor of four that corresponds to the ideal Hþ:e– ratio, we approx-
imate the corresponding proton efflux rate as (23)
JHres;F ¼ 8JO;F; (35)
where JO,F and JHres,F have the same qualitative behavior as JO,N (Fig. S4).
ATP production
One turn of the TCA cycle results in the production of one GTP molecule,
which we assume is converted immediately to an ATP molecule by the
nucleotide diphosphate kinase. We approximate the glucose-dependent
rate of ATP production from the TCA cycle in our model as (25)
JTCA;Glu ¼ 2p22Jgly

Cam
p23 þ Cam

; (36)
which has the same qualitative behavior as JN,Glu (Fig. S3).
ATP is also produced by the F1F0-ATP synthase, which harnesses the energy
stored in DJ. Magnus and Keizer (23) modeled the ATP production rate of
this reaction as~JF1F0 ¼ rF1F0

da10
3DpH þ dc1e
3FDJB
RT

e
FAF1F0
RT  dae
3g2FDJ
RT þ dc2e
FAF1F0
RT e
3g2FDJ
RT
1 þ d1e
FAF1F0
RT

e
3FDJB
RT þ

d2 þ d3e
FAF1F0
RT

e
3g2FDJ
RT
;where
AF1F0 ¼ RT
F
ln

KF1F0ATPm
0:8ADPmPim

;
and where rF1F0¼ 1800 mM from Bertram et al. (16) and Cortassa et al. (24),
g2 ¼ 1.07, da ¼ 1.656  108/ms, dc1 ¼ 9.651  1017/ms, dc2 ¼ 4.845 
1022/ms, d1 ¼ 1.346  108, d2 ¼ 7.739  107, d3 ¼ 6.65  1015,
KF1F0 ¼ 1.71  106 mM, and Pim ¼ 20 mM. The value g2 was used here
to shift the inflection point of the DJ-dependent curve to lower DJ inBiophysical Journal 98(2) 207–217agreement with the shifts made in ~JO;N and ~JO;F above. We approximate
~JF1F0 in our model with the simpler formJF1F0 ¼ p24ADPm

1
ðp26DJÞ=p27

: (37)ADPm þ p25ATPm 1 þ e
Fig. S5 illustrates the ATP production rate from the F1F0-ATP synthase, as
calculated by the two models. Using a factor of three that corresponds to the
ideal Hþ:Pi ratio, we approximate the proton influx through the F1F0-ATP
synthase as
JH;ATP ¼ 3JF1F0; (38)
which has the same qualitative behavior as JF1F0 (Fig. S5).
The rate of ATP transport out of the mitochondrial matrix through the ANT
exchanger was modeled by Magnus and Keizer (23) as
~JANT ¼ Jmax;ANT
1 a1ATPiADPm
ADPiATPm
e
FDJ
RT
1 þ a2ATPi
ADPi
e
fFDJ
RT

1 þ a3ADPm
ATPm
;
where Jmax,ANT ¼ 20.8 mM/ms, a1 ¼ 0.8, a2 ¼ 0.11, f ¼ 0.5, and a3 ¼ 7.2.
The value ADPi is the intracellular ADP concentration (mM). To simplify
this expression, we assume the intracellular and mitochondrial matrix nucle-
otide ratios are maintained at approximately equal values by the transporter
(16), i.e., ATPi/ADPi z ATPm/ADPm, so that
~JANTzJmax;ANT
1 a1eFDJRT
1 þ a2ATPm
ADPm
e
fFDJ
RT

1 þ a3ADPm
ATPm
:We approximate ~JANT in our model with the simpler formJANT ¼ p28ATPm
ADPm þ p29ATPme
p30DJ: (39)
Fig. S6 illustrates the ANT exchange rate, as calculated by the two
models.
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